Competitive Landscape by Indication

Data updated: Jul 17, 2026

158 indications, 116,822 trials mapped

Oncology

54,943 trials

Solid Tumor (Advanced)

9535 trials 880 Ph3

Merck, GSK, Sichuan Baili Pharmaceutical Co., Ltd.

3952 trials 706 Ph3

AstraZeneca, Roche, Pfizer

Non-Hodgkin Lymphoma

3905 trials 347 Ph3

Roche, Merck, Genmab

3407 trials 552 Ph3

AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.

Colorectal Cancer

2599 trials 365 Ph3

AbbVie, AstraZeneca, Revolution Medicines, Inc.

Prostate Cancer

2297 trials 351 Ph3

Novartis, AstraZeneca, Jiangsu HengRui Medicine Co., Ltd.

Multiple Myeloma

1930 trials 231 Ph3

Johnson & Johnson, GSK, AbbVie

1805 trials 171 Ph3

AbbVie, Taiho Oncology, Inc., Kura Oncology, Inc.

Hematologic Malignancies

1726 trials 151 Ph3

Johnson & Johnson, Novartis, Merck

1661 trials 140 Ph3

Bristol-Myers Squibb, Merck, Regeneron

Pancreatic Cancer

1582 trials 137 Ph3

Revolution Medicines, Inc., AstraZeneca, Astellas

Hepatocellular Carcinoma

1421 trials 218 Ph3

AstraZeneca, Akeso, Roche

1388 trials 160 Ph3

AstraZeneca, AbbVie, Genmab

Lung Cancer (General)

1310 trials 168 Ph3

Chongqing Precision Biotech Co., Ltd, AstraZeneca, Avistone Biotechnology Co., Ltd.

Head and Neck Cancer

1240 trials 112 Ph3

Sichuan Baili Pharmaceutical Co., Ltd., AstraZeneca, Rakuten Medical, Inc.

1180 trials 96 Ph3

Bristol-Myers Squibb, Takeda, Taiho Oncology, Inc.

1089 trials 185 Ph3

AstraZeneca, Astellas, Chongqing Precision Biotech Co., Ltd

1047 trials 73 Ph3

USWM CT, LLC, Hansoh BioMedical R&D Company, Eli Lilly

982 trials 136 Ph3

Merck, AstraZeneca, Pfizer

972 trials 64 Ph3

Novartis, GT Medical Technologies, Inc., Philogen S.p.A.

940 trials 90 Ph3

Novartis, Amgen, Chongqing Precision Biotech Co., Ltd

793 trials 56 Ph3

Pfizer, InSightec, Jazz Pharmaceuticals

Esophageal Cancer

792 trials 133 Ph3

AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.

777 trials 82 Ph3

BeOne Medicines, Acerta Pharma BV, AbbVie

Renal Cell Carcinoma

776 trials 73 Ph3

Merck, Exelixis, Bristol-Myers Squibb

Squamous Cell Carcinoma

646 trials 64 Ph3

Regeneron, Merck, AstraZeneca

Triple Negative Breast Cancer

596 trials 67 Ph3

Gilead, Novartis, AstraZeneca

Cholangiocarcinoma

587 trials 60 Ph3

AstraZeneca, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Eli Lilly

559 trials 71 Ph3

Amgen, Boehringer Ingelheim, Merck

Cervical Cancer

530 trials 89 Ph3

AstraZeneca, Merck, Shanghai Bovax Biotechnology Co., Ltd.

Hodgkin Lymphoma

480 trials 36 Ph3

Merck, Takeda, Tessa Therapeutics

Endometrial Cancer

457 trials 48 Ph3

AstraZeneca, Merck, Genmab

399 trials 44 Ph3

Novartis, Shenzhen TargetRx Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd.

Neuroendocrine Tumors

327 trials 42 Ph3

Advanced Accelerator Applications, Crinetics Pharmaceuticals Inc., Merck

283 trials 35 Ph3

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Novartis, Bristol-Myers Squibb

278 trials 17 Ph3

Novartis, AstraZeneca, NGM Biopharmaceuticals, Inc

228 trials 34 Ph3

Exelixis, Eli Lilly, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

HER2+ Breast Cancer

188 trials 33 Ph3

Sichuan Baili Pharmaceutical Co., Ltd., Roche, Jazz Pharmaceuticals

HER2- Breast Cancer

178 trials 19 Ph3

AstraZeneca, Novartis, BeOne Medicines

Merkel Cell Carcinoma

101 trials 6 Ph3

TuHURA Biosciences, Inc., ImmunityBio, Inc., AstraZeneca

CNS

10,438 trials

Major Depression

1773 trials 474 Ph3

Neurocrine Biosciences, Johnson & Johnson, COMPASS Pathways

Alzheimer's Disease

1524 trials 290 Ph3

Eli Lilly, Bristol-Myers Squibb, Roche

945 trials 253 Ph3

Neurocrine Biosciences, Luye Pharma Group Ltd., Bristol-Myers Squibb

Parkinson's Disease

926 trials 172 Ph3

iRegene Therapeutics Co., Ltd., Roche, Luye Pharma Group Ltd.

Multiple Sclerosis

863 trials 233 Ph3

Roche, Novartis, Sanofi

513 trials 195 Ph3

AbbVie, Pfizer, H. Lundbeck A/S

467 trials 170 Ph3

Praxis Precision Medicines, UCB Biopharma SRL, Biohaven Therapeutics Ltd.

460 trials 105 Ph3

VistaGen Therapeutics, Inc., Beijing Union Pharmaceutical Factory Ltd, Definium Therapeutics US, Inc.

Alcohol Use Disorder

446 trials 72 Ph3

Eli Lilly, Pop Test Oncology LLC, Newleos Therapeutics, Inc.

Opioid Use Disorder

428 trials 91 Ph3

Go Medical Industries Pty Ltd, Akyso Therapeutics, LLC, Eli Lilly

350 trials 71 Ph3

Eli Lilly, Biogen, Amylyx Pharmaceuticals Inc.

Autism Spectrum Disorder

336 trials 64 Ph3

Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Curemark

334 trials 119 Ph3

Otsuka Pharmaceutical Co., Ltd., Boehringer Ingelheim, Bazelet Nehushtan LtD.

310 trials 62 Ph3

Oui Therapeutics, Inc., COMPASS Pathways, Senseye, Inc.

Bipolar Disorder

290 trials 96 Ph3

Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Xenon Pharmaceuticals Inc.

283 trials 70 Ph3

argenx, WinSanTor, Inc, Rinri Therapeutics

Huntington's Disease

106 trials 18 Ph3

Roche, Skyhawk Therapeutics, Inc., Novartis

84 trials 11 Ph3

Vericel Corporation, Biohaven Pharmaceuticals, Inc., Roche

Infectious Disease

9,976 trials

2282 trials 448 Ph3

Gilead, ViiV Healthcare, Merck

2249 trials 740 Ph3

Pfizer, BioNTech SE, Invivyd, Inc.

1169 trials 327 Ph3

GSK, Valenta Pharm JSC, Changchun BCHT Biotechnology Co.

1014 trials 294 Ph3

Atea Pharmaceuticals, Inc., Gilead, Merck

633 trials 109 Ph3

Ausper Biopharma Co., Ltd., Beijing Continent Pharmaceutical Co, Ltd., GSK

599 trials 129 Ph3

GSK, Sanaria Inc., Novartis

487 trials 159 Ph3

AstraZeneca, ImmunityBio, Inc., Bayer

481 trials 118 Ph3

Shanghai Jiatan Pharmatech Co., Ltd, Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc.

286 trials 70 Ph3

GSK, Pfizer, Shenzhen Shenxin Biotechnology Co., Ltd

Fungal Infections

221 trials 68 Ph3

Merck, F2G Biotech GmbH, Basilea Pharmaceutica

206 trials 49 Ph3

ARJ Medical, Inc., Catalysis SL, Xuanzhu Biopharmaceutical Co., Ltd.

176 trials 45 Ph3

AstraZeneca, Vedanta Biosciences, Inc., Acurx Pharmaceuticals Inc.

Bacterial Infections

173 trials 35 Ph3

Pfizer, Qpex Biopharma, Inc., CanSino Biologics Inc.

Metabolic

8,920 trials

Type 2 Diabetes

2733 trials 839 Ph3

Eli Lilly, Novo Nordisk, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

1731 trials 390 Ph3

Eli Lilly, Novo Nordisk, Amgen

Diabetes (General)

1618 trials 407 Ph3

Gan & Lee Pharmaceuticals., Novo Nordisk, Eli Lilly

Type 1 Diabetes

814 trials 179 Ph3

Eli Lilly, Sanofi, Novo Nordisk

727 trials 280 Ph3

Addpharma Inc., Qilu Pharmaceutical Co., Ltd., Novartis

683 trials 106 Ph3

GSK, Akero Therapeutics, Inc, Corcept Therapeutics

Diabetic Complications

614 trials 140 Ph3

Roche, EyeBiotech Ltd., Regeneron

Cardiovascular

6,999 trials

2172 trials 638 Ph3

Merck, Boryung Pharmaceutical Co., Ltd, Addpharma Inc.

1200 trials 280 Ph3

Novo Nordisk, HELP Therapeutics Co., Ltd., Tasly Pharmaceutical Group Co., Ltd

1164 trials 393 Ph3

Shin Poong Pharmaceutical Co. Ltd., NoNO Inc., Pharmasoft

Coronary Artery Disease

1068 trials 238 Ph3

Novartis, XyloCor Therapeutics, Inc., Beijing Inno Medicine Co., Ltd.

Myocardial Infarction

489 trials 140 Ph3

Novo Nordisk, Beijing Sungen Biomedical Technology Co., Ltd, Beijing Northland Biotech. Co., Ltd.

Atrial Fibrillation

489 trials 145 Ph3

Regeneron, Anthos Therapeutics, Inc., Bayer

278 trials 121 Ph3

Regeneron, Boston Scientific Corporation, Supergene, LLC

83 trials 28 Ph3

Cardurion Pharmaceuticals, Inc., Solid Biosciences Inc., Agiana Pharmaceuticals

Hypertrophic Cardiomyopathy

56 trials 18 Ph3

Shandong Suncadia Medicine Co., Ltd., Cytokinetics, Bristol-Myers Squibb

Immunology

5,698 trials

Rheumatoid Arthritis

1083 trials 290 Ph3

AstraZeneca, AbbVie, Bristol-Myers Squibb

1027 trials 329 Ph3

Johnson & Johnson, Bristol-Myers Squibb, UCB Biopharma SRL

Atopic Dermatitis

822 trials 207 Ph3

Pfizer, AbbVie, Eli Lilly

548 trials 80 Ph3

AstraZeneca, Novartis, Bristol-Myers Squibb

Crohn's Disease

536 trials 151 Ph3

Takeda, Johnson & Johnson, AbbVie

Ulcerative Colitis

534 trials 130 Ph3

Takeda, AbbVie, Roche

Psoriatic Arthritis

185 trials 80 Ph3

UCB Biopharma SRL, AbbVie, Bristol-Myers Squibb

Lupus Nephritis

145 trials 28 Ph3

Novartis, China Immunotech (Beijing) Biotechnology Co., Ltd., Roche

Myasthenia Gravis

140 trials 68 Ph3

UCB Biopharma SRL, argenx, AstraZeneca

Ankylosing Spondylitis

137 trials 45 Ph3

UCB Biopharma SRL, Suzhou Zelgen Biopharmaceuticals Co.,Ltd, Jiangsu vcare pharmaceutical technology co., LTD

IgA Nephropathy

132 trials 40 Ph3

Novartis, Vera Therapeutics, Inc., Chengdu Suncadia Medicine Co., Ltd.

Hidradenitis Suppurativa

131 trials 32 Ph3

Incyte Corporation, Novartis, AbbVie

106 trials 25 Ph3

Disc Medicine, Inc, iCell Gene Therapeutics, Parvus Therapeutics, Inc.

Chronic Spontaneous Urticaria

102 trials 41 Ph3

Novartis, Celldex Therapeutics, Hangzhou Highlightll Pharmaceutical Co., Ltd

70 trials 23 Ph3

AstraZeneca, Amgen, Roche

Pain

4,510 trials

2785 trials 769 Ph3

Eli Lilly, Vertex Pharmaceuticals Incorporated, AFT Pharmaceuticals, Ltd.

Postoperative Pain

1109 trials 238 Ph3

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., Shanghai Huilun Pharmaceutical Co., Ltd., Pacira Pharmaceuticals, Inc

Neuropathic Pain

323 trials 55 Ph3

Vertex Pharmaceuticals Incorporated, Eli Lilly, Haisco Pharmaceutical Group Co., Ltd.

293 trials 74 Ph3

Eli Lilly, Evon Medics LLC, iN Therapeutics Co., Ltd.

Respiratory

4,447 trials

1432 trials 385 Ph3

AstraZeneca, GSK, Sanofi

1184 trials 352 Ph3

AstraZeneca, Haisco Pharmaceutical Group Co., Ltd., GSK

522 trials 184 Ph3

GSK, Qilu Pharmaceutical Co., Ltd., Pfizer

Cystic Fibrosis

483 trials 132 Ph3

Vertex Pharmaceuticals Incorporated, Sionna Therapeutics Inc., Boehringer Ingelheim

Allergic Rhinitis

372 trials 139 Ph3

Genrix (Shanghai) Biopharmaceutical Co., Ltd., Guangdong Hengrui Pharmaceutical Co., Ltd, Prime Gene Therapeutics Co., Ltd.

Idiopathic Pulmonary Fibrosis

309 trials 55 Ph3

Boehringer Ingelheim, Bristol-Myers Squibb, Sunshine Lake Pharma Co., Ltd.

Chronic Rhinosinusitis with Nasal Polyps

145 trials 57 Ph3

Sanofi, Keymed Biosciences Co.Ltd, AstraZeneca

Musculoskeletal

1,753 trials

1055 trials 282 Ph3

Eli Lilly, Pacira Pharmaceuticals, Inc, TBF Genie Tissulaire

372 trials 101 Ph3

Amgen, Shenzhen Salubris Pharmaceuticals Co., Ltd., Qilu Pharmaceutical Co., Ltd.

230 trials 52 Ph3

Crystalys Therapeutics, Jiangsu HengRui Medicine Co., Ltd., Atom Therapeutics Co., Ltd

96 trials 46 Ph3

Chongqing Claruvis Pharmaceutical Co., Ltd., Ipsen, Merz Pharmaceuticals GmbH

Ophthalmology

1,557 trials

Age-Related Macular Degeneration

550 trials 132 Ph3

Roche, AbbVie, EyeBiotech Ltd.

524 trials 149 Ph3

Glaukos Corporation, SpyGlass Pharma, Inc., AbbVie

483 trials 138 Ph3

AbbVie, Laboratorios Sophia S.A de C.V., Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Gastrointestinal

1,417 trials

Nausea/Vomiting

388 trials 119 Ph3

Helsinn Healthcare SA, Eli Lilly, Vanda Pharmaceuticals

364 trials 96 Ph3

MediWound Ltd, Cellution Biologics, TR Therapeutics

294 trials 110 Ph3

Ardelyx, Shionogi, Eli Lilly

224 trials 64 Ph3

Bausch Health Americas, Inc., Crinetics Pharmaceuticals Inc., Tasly Pharmaceutical Group Co., Ltd

147 trials 45 Ph3

Cinclus Pharma Holding AB, Takeda, Addpharma Inc.

Rare Disease

1,400 trials

Sickle Cell Disease

369 trials 71 Ph3

Novartis, Forma Therapeutics, Inc., Vertex Pharmaceuticals Incorporated

Immune Thrombocytopenia

368 trials 111 Ph3

Novartis, argenx, Jiangsu HengRui Medicine Co., Ltd.

291 trials 129 Ph3

Pfizer, Roche, CSL Behring

Duchenne Muscular Dystrophy

166 trials 36 Ph3

Sarepta Therapeutics, Inc., NS Pharma, Inc., Italfarmaco

Spinal Muscular Atrophy

61 trials 22 Ph3

GeneCradle Inc, Biogen, Roche

61 trials 28 Ph3

Amicus Therapeutics, Chiesi Farmaceutici S.p.A., Sanofi

Gaucher Disease

51 trials 18 Ph3

Spur Therapeutics, Prevail Therapeutics, Genzyme, a Sanofi Company

28 trials 5 Ph3

Blueprint Medicines Corporation, Cogent Biosciences, Inc., MacroGenics

CDKL5 Deficiency Disorder

Zogenix, Inc., Immedica Pharma AB, Marinus Pharmaceuticals

Women's Health

1,084 trials

490 trials 168 Ph3

IBSA Institut Biochimique SA, Qilu Pharmaceutical Co., Ltd., Fertility Center of Las Vegas

203 trials 59 Ph3

Wellizen Australia, Fujian Shengdi Pharmaceutical Co., Ltd., Dexa Medica Group

182 trials 50 Ph3

Bayer, Astellas, AbCellera Biologics Inc.

162 trials 44 Ph3

AbbVie, Kissei Pharmaceutical Co., Ltd., Hope Medicine (Nanjing) Co., Ltd

47 trials 13 Ph3

YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences

Renal

1,069 trials

Chronic Kidney Disease

847 trials 244 Ph3

AstraZeneca, Eli Lilly, Bayer

Acute Kidney Injury

222 trials 57 Ph3

Ebima Clifford Okundaye, Arch Biopartners Inc., Vantive Health LLC

Dermatology

937 trials

384 trials 112 Ph3

AbbVie, Sanofi, Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

255 trials 63 Ph3

Applied Biology, Inc., Veradermics, Inc., Pfizer

125 trials 39 Ph3

Tarsus Pharmaceuticals, Inc., Novartis, Galderma R&D

114 trials 33 Ph3

Incyte Corporation, Pfizer, Jiangsu HengRui Medicine Co., Ltd.

Skin Infections

59 trials 17 Ph3

GSK, Melinta Therapeutics, Inc., Durata Therapeutics Inc., an affiliate of Allergan plc

Urology

644 trials

Overactive Bladder

315 trials 89 Ph3

Levee Medical, Inc., Cook MyoSite, TBF Genie Tissulaire

Erectile Dysfunction

184 trials 54 Ph3

Aspargo Labs, Inc, EMS, Biozeus Biopharmaceutical S.A.

Benign Prostatic Hyperplasia

145 trials 47 Ph3

Resurge Therapeutics Inc., Addpharma Inc., AJU Pharm Co., Ltd.

Hepatology

437 trials

357 trials 100 Ph3

AstraZeneca, Yaqrit Ltd, Gilead

80 trials 14 Ph3

Yaqrit Ltd, Genfit, eGenesis, INC

Sleep

346 trials

269 trials 67 Ph3

Jiangsu Hansoh Pharmaceutical Co., Ltd., Merck, Sequential Medicine Ltd

77 trials 29 Ph3

Takeda, Alkermes, Inc., Centessa Pharmaceuticals (UK) Limited

Endocrine

247 trials

Growth Hormone Deficiency

97 trials 35 Ph3

Changchun GeneScience Pharmaceutical Co., Ltd., Lumos Pharma, Xiamen Amoytop Biotech Co., Ltd.

51 trials 17 Ph3

Marea Therapeutics, Crinetics Pharmaceuticals Inc., Debiopharm International SA

41 trials 10 Ph3

AbbVie, IBSA Institut Biochimique SA, Neuvosyn Laboratories, LLC

Adrenal Insufficiency

31 trials 6 Ph3

Neurocrine UK Limited

Hyperthyroidism

27 trials 8 Ph3

Biohaven Therapeutics Ltd., argenx, Merida Biosciences

Click any indication to see full competitive landscape (all sponsors, trials, phases).

Data: ClinicalTrials.gov | Mapping: Indication Taxonomy